PMID: 9438480Jan 23, 1998Paper

The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, noninfectious perennial rhinitis

The Journal of Allergy and Clinical Immunology
H BlomE Rijntjes

Abstract

Topical corticosteroids are the therapy of choice for nonallergic, noninfectious perennial rhinitis (NANIPER). However, the efficacy of steroid therapy in NANIPER is controversial, as is its mode of action. To our surprise, of 300 patients initially diagnosed as having NANIPER, only 65 reached threshold nasal symptom scores. Patients were randomized into four different treatment regimens: placebo administered twice daily (BD) for 8 weeks, fluticasone propionate aqueous nasal spray (FPANS) (200 microg) once daily (OD) and placebo OD for 8 weeks, FPANS (200 microg) OD and placebo OD for 4 weeks followed by FPANS (200 microg) BD for 4 weeks, and FPANS (200 microg) BD for 8 weeks. A small decrease in nasal symptoms was found, which only reached significance for sneezing in the FPANS 200 microg BD group. A significant dose-dependent decrease in immunocompetent cells was found in nasal biopsy specimens obtained before, after 4 weeks, and after 8 weeks of treatment. We conclude that FPANS did not significantly reduce nasal symptoms in this group of selected NANIPER patients, even though a significant effect on cells in the nasal mucosa was seen.

Citations

Mar 29, 2002·Current Allergy and Asthma Reports·Wytske J Fokkens
Mar 29, 2006·Current Allergy and Asthma Reports·Jeroen B van Rijswijk, Roy Gerth van Wijk
Apr 29, 2010·Current Allergy and Asthma Reports·Debendra Pattanaik, Phillip Lieberman
Jan 17, 2004·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Michael S BenningerMaureen Hannley
May 9, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·D Robert WebbCindy K Cook
Dec 14, 2011·Current Opinion in Otolaryngology & Head and Neck Surgery·Paul BurnsNick S Jones
Apr 10, 2014·Current Allergy and Asthma Reports·Phil Lieberman, Debendra Pattanaik
Nov 4, 2005·Allergy·J B van RijswijkW J Fokkens
Dec 2, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T Groot KormelinkF A Redegeld
Jan 19, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R J SalibP H Howarth
Apr 17, 2016·Immunology and Allergy Clinics of North America·Phillip L Lieberman, Peter Smith
Jul 9, 2011·Immunology and Allergy Clinics of North America·Michael A Kaliner
Jul 20, 2016·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A O Eifan, S R Durham
Apr 9, 2017·The Journal of Allergy and Clinical Immunology·Laura Van GervenPeter W Hellings
Sep 21, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A KleinjanW J Fokkens
Nov 21, 1998·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H M BlomW J Fokkens
May 8, 2002·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J P M BraatW J Fokkens
Sep 12, 2015·American Journal of Rhinology & Allergy·Virat KirtsreesakulSuwalee Ruttanaphol
Mar 25, 2005·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Ipek TurktasArzu Bakirtas
Dec 17, 2009·Current Opinion in Allergy and Clinical Immunology·Carmen RondónMiguel Blanca
Nov 5, 2019·The Cochrane Database of Systematic Reviews·Christine SegboerWytske Fokkens
May 22, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A F Holm, W J Fokkens
Jun 26, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·D G PoweN S Jones
Jan 16, 2010·International Journal of Immunopathology and Pharmacology·G Di LorenzoR Corrocher
Jul 1, 2017·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G K ScaddingA T Clark
Oct 13, 2020·International Forum of Allergy & Rhinology·Denna ZebdaAmber U Luong
Dec 2, 2020·Expert Review of Clinical Immunology·Yifan MengLuo Zhang
Nov 15, 2001·The Journal of Allergy and Clinical Immunology·J BousquetUNKNOWN World Health Organization

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
H BlomE Rijntjes
© 2021 Meta ULC. All rights reserved